SPOTLIGHT -
The Limitations and Promise of Immunotherapy With Chimeric Antigen–Modified T Cells
Identification of effective lymphodepletion strategies, optimization of patient selection, and management of novel toxicities remain challenges in the growing field of cellular immunotherapy.
